A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma

NCT06333821 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

460

Enrollment

OTHER

Sponsor class

Conditions

Cervical Cancer

Interventions

BIOLOGICAL: Nimotuzumab
DRUG: Cisplatin
RADIATION: External Beam Radiotherapy (EBRT)
RADIATION: Brachytherapy
DRUG: placebo for Nimotuzumab

Sponsor

Biotech Pharmaceutical Co., Ltd.